UnitedHealth Group (NYSE:UNH) Announces Earnings Results

UnitedHealth Group (NYSE:UNH) released its earnings results on Tuesday. The healthcare conglomerate reported $7.23 EPS for the quarter, topping the consensus estimate of $6.76 by $0.47, FiscalAI reports. UnitedHealth Group had a return on equity of 14.79% and a net margin of 2.69%.The business had revenue of $111.65 billion during the quarter, compared to analysts’ expectations of $109.84 billion. During the same quarter last year, the firm posted $7.20 earnings per share. The firm’s revenue was up 2.0% on a year-over-year basis. UnitedHealth Group updated its FY 2026 guidance to 18.250- EPS.

Here are the key takeaways from UnitedHealth Group’s conference call:

• UnitedHealth delivered a strong Q1 beat with adjusted EPS $7.23, revenue of $111.7B, an improved medical care ratio of 83.9%, updated full?year outlook to >$18.25, and accelerated at least $2B of share repurchases.
• Optum Health outperformed with $1.3B of adjusted earnings driven by operational improvements and favorable prior?period reserve development, but management cautioned some of the benefit is non?recurring and performance will normalize through 2026–27.
• The company is investing nearly $1.5B in AI in 2026; management expects Optum Insight’s AI?first products to scale commercially (early traction cited) with a conservative ~2:1 return on those programs.
• Elevated utilization and program pressures persist—management expects about a 1.3M Medicare membership contraction, the ACA book to shrink ~33%, and Medicaid to show negative margins in 2026 (modest improvement expected in 2027).
• Operational/digital progress may reduce costs and friction—prior authorizations are ~95% electronic (?50% real?time), digital member engagement and provider portal use are rising (73M digital visits in Q1), and Optum Rx/PreCheck innovations materially speed approvals.

UnitedHealth Group Stock Performance

Shares of UNH opened at $346.26 on Wednesday. The firm has a market capitalization of $314.29 billion, a P/E ratio of 26.25, a P/E/G ratio of 1.49 and a beta of 0.40. UnitedHealth Group has a 52 week low of $234.60 and a 52 week high of $438.85. The stock has a 50 day moving average price of $289.27 and a two-hundred day moving average price of $316.84. The company has a debt-to-equity ratio of 0.72, a quick ratio of 0.79 and a current ratio of 0.79.

UnitedHealth Group Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, March 17th. Shareholders of record on Monday, March 9th were paid a dividend of $2.21 per share. The ex-dividend date was Monday, March 9th. This represents a $8.84 dividend on an annualized basis and a yield of 2.6%. UnitedHealth Group’s payout ratio is 67.02%.

Key Headlines Impacting UnitedHealth Group

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: Q1 results beat expectations and company raised FY outlook — UnitedHealth reported stronger-than-expected Q1 revenue and EPS and now targets FY 2026 adjusted net earnings of greater than $18.25 per share, which underpins the positive market reaction. UnitedHealth Group Reports First Quarter 2026 Results
• Positive Sentiment: Beating the street on key metrics — Q1 EPS of $7.23 and revenue ~ $111.6B topped consensus, signaling improved margin control and driving investor confidence. UNH Earnings Details
• Positive Sentiment: AI and operational investments seen as growth catalysts — Management flagged meaningful AI spending (including Optum Real scale-up) to streamline claims and payments; investors view this as a path to sustainable efficiency gains. UnitedHealth’s AI Is Rebuilding the Payment Layer of American Healthcare
• Positive Sentiment: Analyst upgrades and higher price targets — Multiple firms raised ratings/targets after the beat: Argus upgraded to Buy with a $400 target, Truist reaffirmed Buy and lifted its target to $395, and Jefferies boosted its target to $373 — reinforcing upside thesis. Argus Upgrade Truist Reaffirmation Jefferies Price Target Raise
• Neutral Sentiment: Operational initiatives to simplify care (rural prior?authorization changes) could improve provider relations but are longer?term positives rather than immediate earnings drivers. Rural Prior Authorization Changes
• Negative Sentiment: Regulatory/Medicare program uncertainty — UnitedHealth warned of “challenges” around a Medicare obesity?drug pilot (adds enrollment/payment uncertainty) which could limit upside if insurers opt out or payments change. Medicare Obesity Drug Pilot Challenges
• Negative Sentiment: Ongoing Medicare/payment headwinds — Earlier reporting flagged potential multi?billion?dollar Medicare impacts and persistent medical?cost risk; investors should watch upcoming guidance and membership trends for sustainability. Medicare Payment Overhaul Risk

Hedge Funds Weigh In On UnitedHealth Group

Several large investors have recently bought and sold shares of the stock. Caitlin John LLC grew its stake in shares of UnitedHealth Group by 3.9% in the 4th quarter. Caitlin John LLC now owns 1,064 shares of the healthcare conglomerate’s stock worth $351,000 after acquiring an additional 40 shares in the last quarter. Riggs Asset Managment Co. Inc. raised its holdings in shares of UnitedHealth Group by 69.4% in the second quarter. Riggs Asset Managment Co. Inc. now owns 105 shares of the healthcare conglomerate’s stock valued at $33,000 after purchasing an additional 43 shares during the last quarter. Riverwater Partners LLC boosted its holdings in UnitedHealth Group by 1.9% during the fourth quarter. Riverwater Partners LLC now owns 2,458 shares of the healthcare conglomerate’s stock worth $811,000 after purchasing an additional 45 shares during the last quarter. Safeguard Investment Advisory Group LLC increased its stake in UnitedHealth Group by 1.2% in the 4th quarter. Safeguard Investment Advisory Group LLC now owns 3,822 shares of the healthcare conglomerate’s stock valued at $1,262,000 after buying an additional 45 shares during the last quarter. Finally, Sittner & Nelson LLC boosted its stake in shares of UnitedHealth Group by 7.2% in the 3rd quarter. Sittner & Nelson LLC now owns 682 shares of the healthcare conglomerate’s stock worth $236,000 after buying an additional 46 shares during the last quarter. 87.86% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of research analysts recently issued reports on the stock. Sanford C. Bernstein boosted their target price on shares of UnitedHealth Group from $405.00 to $411.00 and gave the company an “outperform” rating in a research report on Tuesday, April 7th. Oppenheimer decreased their price target on shares of UnitedHealth Group from $415.00 to $385.00 and set an “outperform” rating for the company in a research note on Wednesday, January 28th. KeyCorp restated an “overweight” rating on shares of UnitedHealth Group in a research note on Wednesday, January 28th. HSBC raised UnitedHealth Group from a “reduce” rating to a “hold” rating and set a $300.00 price target on the stock in a research note on Tuesday, April 7th. Finally, Mizuho decreased their price objective on UnitedHealth Group from $430.00 to $350.00 and set an “outperform” rating for the company in a report on Thursday, February 5th. One research analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating, seven have assigned a Hold rating and two have assigned a Sell rating to the company. According to MarketBeat, UnitedHealth Group has a consensus rating of “Moderate Buy” and a consensus price target of $367.20.

UnitedHealth Group Company Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.